NCT06943209 SAPLAI : Assessing the faiSAbility of a Peer-to-peer Contraceptive Education Program on Social Networks Aimed at 15- to 19-year-old High School Students in GuAdeloupe and La RéunIon
| NCT ID | NCT06943209 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de la Réunion |
| Condition | Contraception Behavior |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-04-29 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-04-29 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the feasibility of a contraception education program delivered by peers via social networks to high school students. Our primary hypothesis is that the implementation of a peer-led contraceptive education program via social networks is a feasible approach in high schools on Reunion Island and Guadeloupe, as part of a before-and-after study. Our secondary hypotheses concern the evaluation of adoption, exploratory efficacy (on knowledge, attitudes and practices), acceptability and fidelity of the peer-led education program via social networks among high school students in La Réunion and Guadeloupe. Participants will : * Participate in a focus group to explore their views and experiences regarding the value of a peer educator as a source of sexual and reproductive health information. * answer questionnaires on their knowledge of sexual health * A selected group (peer influencers): Create educational content (after a training period) on sexual health, and particularly contraception, to be broadcast on social networks. * Take note of the program distributed on the networks by the peer influencers (for 3 months) * Fill in questionnaires on their knowledge of sexual health, after the program.
Eligibility Criteria
Inclusion Criteria: * HIGH SCHOOL STUDENTS * Young men and women aged between 15 and 19 * Living in La Réunion or Guadeloupe * Enrolled in one of the selected vocational high schools and whose school principal agrees to take part in the program * Who have agreed to take part in the study * Who have received written consent from a parent or guardian. PEER INFLUENCERS * Young men and women aged between 15 and 19 * Living in La Réunion or Guadeloupe * Enrolled in one of the selected vocational high schools and whose school principal agrees to participate in the program * Selected in seconde class and admitted to première class * Have been chosen as a peer * Have a sense of self-efficacy in the use of computers * Have good communication skills * Possession of a video-capable smartphone * Having agreed to take part in the study * Written consent from a parent or guardian Exclusion Criteria: \- Involved in other similar programs
Contact & Investigator
Danielle REYNAUD
PRINCIPAL INVESTIGATOR
CHU REUNION
Frequently Asked Questions
Who can join the NCT06943209 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 19 Years, studying Contraception Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943209 currently recruiting?
Yes, NCT06943209 is actively recruiting participants. Contact the research team at danielle.reynaud@chu-reunion.fr for enrollment information.
Where is the NCT06943209 trial being conducted?
This trial is being conducted at Port-Louis, Guadeloupe, Saint-Paul, Reunion.
Who is sponsoring the NCT06943209 clinical trial?
NCT06943209 is sponsored by Centre Hospitalier Universitaire de la Réunion. The principal investigator is Danielle REYNAUD at CHU REUNION. The trial plans to enroll 120 participants.